ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q1Scopus Q1SCImago #335Top JournalHybrid

Blood Cancer Discovery

Identifier (ISSN):2643-3230(Print)/2643-3249(Online)
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
12.2↑ +0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS ESCITop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Blood Cancer Discovery

WoS Q1
710131611.2202311.5202411.5202512.22026
Annual Impact Factor Metric
Current (2026):12.2
Scopus SJR & RankScopus Q1
4.623
#335

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
35

35 papers with at least that number of citations each

WoS: ESCITop Tier
Self-Citation Rate1.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
45articles/year
41.46% Gold OA•96.88% Original Research

Aims & Scope

Blood Cancer Discovery (ISSN: 2643-3230) is a peer-reviewed international scholarly journal in the field of Multiple, published by reputable academic bodies. The periodical holds a Journal Impact Factor (JIF) of 12.2, ranking in quartile Q1 of Web of Science (ESCI), a Scopus SJR indicator of 4.623 (Q1), an H-index of 35.

Topics Covered (Recognized by AI)
Biology73.8%Medicine72.3%Genetics71.2%Internal medicine69.3%Immunology65.5%Cancer research53.9%Chemistry53.6%Biochemistry52.1%Gene41.6%Pathology41.6%Cancer30.7%Cell biology28.1%Leukemia23.2%Immune system20.6%Lymphoma20.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

HEMATOLOGY

Q1
Rank7/103
IndexESCI
JCRESCI2026

ONCOLOGY

Q1
Rank28/333
IndexESCI
JCIESCI2026

HEMATOLOGY

Q1
Rank5/103
IndexESCI
JCIESCI2026

ONCOLOGY

Q1
Rank21/333
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

7 year
2026Latest
IF12.2
Articles / Year138
Total Citations24
2025
IF11.5
Articles / Year71
Total Citations329
2024
IF11.5
Articles / Year123
Total Citations564
2023
IF11.2
Articles / Year100
Total Citations977
2022
IF—
Articles / Year92
Total Citations1,261

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #335Scopus Q1SCImago Profile
Scopus Coverage:2020-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
4.623

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
7.30

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,398 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations958
3-Year Documents124
Citable Documents121

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1
Cancer ResearchQ1
HematologyQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Blood Cancer Discovery (ISSN: 2643-3230) is a peer-reviewed international scholarly journal in the field of Multiple, published by reputable academic bodies. The periodical holds a Journal Impact Factor (JIF) of 12.2, ranking in quartile Q1 of Web of Science (ESCI), a Scopus SJR indicator of 4.623 (Q1), an H-index of 35.

The journal enforces rigorous peer evaluation with an annual output of approximately 45 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,398 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Updating
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: bf086959-1765-4f01-b231-198f32af343b
Database Updated: 2026-10-01